Global Financial Private Capital’s GSK GSK Stock Holding History

Global Financial Private Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$5.93M	Sell	114,828 -31,079	-21%	-$1.59M	0.37%	76
2020 Q1	$7.03M	Sell	145,907 -30,445	-17%	-$1.62M	0.45%	70
2019 Q4	$10.5M	Sell	176,352 -17,430	-9%	-$970K	0.53%	55
2019 Q3	$10.4M	Sell	193,782 -24,388	-11%	-$1.25M	0.53%	58
2019 Q2	$10.9M	Sell	218,170 -26,043	-11%	-$1.31M	0.53%	60
2019 Q1	$12.8M	Sell	244,213 -10,973	-4%	-$548K	0.61%	44
2018 Q4	$12.2M	Sell	255,186 -136,660	-35%	-$6.73M	0.66%	41
2018 Q3	$19.7M	Sell	391,846 -89,905	-19%	-$4.57M	0.71%	33
2018 Q2	$24.3M	Sell	481,751 -51,874	-10%	-$2.61M	0.82%	34
2018 Q1	$26.1M	Sell	533,625 -49,717	-9%	-$2.32M	0.91%	32
2017 Q4	$25.9M	Sell	583,342 -30,760	-5%	-$1.42M	0.89%	34
2017 Q3	$31.2M	Buy	614,102 +170,062	+38%	+$8.63M	1.12%	24
2017 Q2	$23.9M	Buy	444,040 +63,706	+17%	+$3.4M	1.16%	27
2017 Q1	$20M	Buy	+380,334	New	+$19.3M	1.01%	33

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Global Financial Private Capital's GSK Position: Q2 2020 in Review

Global Financial Private Capital reduced its GSK (GSK) stake by 21% in Q2 2020, selling an estimated $1.59M and leaving 114,828 shares worth $5.93M. The position accounts for 0.37% of the portfolio, ranked #76.

Global Financial Private Capital first reported a position in GSK in Q1 2017 and has held it in 14 quarters since. The position peaked at $31.2M in Q3 2017. 841 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

Global Financial Private Capital held 114,828 shares of GSK worth $5.93M as of Q2 2020.
Global Financial Private Capital sold 31,079 GSK shares in Q2 2020, an estimated $1.59M.
GSK made up 0.37% of Global Financial Private Capital's portfolio in Q2 2020, its #76 holding.
Global Financial Private Capital first reported a position in GSK in Q1 2017 and has held it in 14 quarters since.
Global Financial Private Capital's GSK position peaked at $31.2M in Q3 2017.
841 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Global Financial Private Capital's 13F filing for Q2 2020, filed 11 Aug 2020.